A detailed history of Alpha Dna Investment Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 3,977 shares of NTRA stock, worth $665,193. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,977
Holding current value
$665,193
% of portfolio
0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$97.75 - $129.67 $388,751 - $515,697
3,977 New
3,977 $505,000
Q2 2021

Aug 10, 2021

SELL
$86.05 - $119.72 $946 - $1,316
-11 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$91.47 - $124.36 $1,006 - $1,367
11 New
11 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.